Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 514-521

  Ruan, Shutian ^a   Raj, B K Mohan ^a   Lloyd, Kenneth O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gangliosides; Glycosyltransferases; Melanoma; Neuroblastoma; Transfection

Indexed keywords

COMPLEMENTARY DNA; GANGLIOSIDE; GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM2; GLYCOSYLTRANSFERASE; MESSENGER RNA;

ARTICLE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0032949037     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720514.x     Document Type: Article

References (26)

1. Caputto R., Maccioni H. J., Arce A., and Cumar F. A. (1971) Biosynthesis of brain gangliosides. Adv. Exp. Med. Biol. 71, 27-44.
2. Carey T. E., Lloyd K. O., Takahashi T., Travassos L. R., and Old L. J. (1979) AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization. Proc. Natl. Acad. Sci. USA 76, 2898-2902.
3. Ciccarone V., Spengler B. A., Meyers M. B., Biedler J. L., and Rossell R. J. (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49, 219-225.
4. Fishman P. H. and Brady R. O. (1976) Biosynthesis and function of gangliosides. Science 194, 906-915.
5. Furukawa K., Clausen H., Hakomori S., Sakamoto J., Look K., Lundblad A., Mattes M. J., and Lloyd K. O. (1985) Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants. Biochemistry 24, 7820-7826.
6. Hakomori S. (1984) Tumor-associated carbohydrate antigens. Annu. Rev. Immunol. 2, 103-126.
7. D2 monoclonal antibody. Proc. Natl. Acad. Sci. USA 91, 10455-10459.
8. Kojima N., Kurosawa N., Nishi T., Hanai N., and Tsuji S. (1994) Induction of cholinergic differentiation with neurite sprouting by de novo biosynthesis and expression of GD3 and b-series gangliosides in Neuro2a cells. J. Biol. Chem. 269, 30451-30456.
9. Kotani M., Ozawa H., Kawashima I., Ando S., and Tai T. (1982) Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim. Biophys. Acta 1117, 97-103.
10. Lloyd K. O. and Furukawa K. (1998) Biosynthesis and functions of gangliosides: recent advances. Glycoconj. J. 15, 627-636.
11. A2 synthesis for utilization of lactosylceramide substrate in vivo. J. Biol. Chem. 269, 29227-29231.
12. D2 gangliosides. J. Biol. Chem. 267, 12082-12089.
13. Nakano J., Raj B. K. M., Asagami C., and Lloyd K. O. (1996) Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics. J. Invest. Dermatol. 107, 543-548.
14. Nara K., Watanabe Y., Maruyama K., Kasahara K., Nagai Y., and Sanai Y. (1994) Expression cloning of a CMP-NeuAc:NeuAcα2-3Galβ1-4Glcβ1-1′Cer α2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc. Natl. Acad. Sci. USA 91, 7952-7956.
15. Pukel C. S., Lloyd K. O., Travassos L. R., Dippold W. G., Oettgen H. F., and Old L. J. (1982) GD3, a prominent ganglioside of human melanoma. Detection and characterization by a mouse monoclonal antibody. J. Exp. Med. 155, 1133-1147.
16. Rebhan M., Vacun G., Bayreuther K., and Rösner H. (1994) Altered ganglioside expression by SH-SY5Y cells upon retinoic acid-induced neuronal differentiation. Neuroreport 5, 941-944.
17. Ruan S. and Lloyd K. O. (1992) Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns. Cancer Res. 52, 5725-5731.
18. Ruan S., Mohan Raj B. K., Furukawa K., and Lloyd K. O. (1995) Analysis of melanoma cells stably transfected with β1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression. Arch. Biochem. Biophys. 323, 11-18.
19. Saito M., Yu R. K., and Cheung N. K. (1985) Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell. Biochem. Biophys. Res. Commun. 127, 1-7.
20. D3 synthase). J. Biol. Chem. 269, 15950-15956.
21. Shitara K., Fujiwara K., Igarashi S., Ohta S., Furuya A., Nakamura K., Koike M., and Hanai N. (1994) Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG. J. Immunol. Methods 169, 83-92.
22. Thampoe I. J., Furukawa K., Vellvé E., and Lloyd K. O. (1989) Sialyltransferase levels and ganglioside expression in melanoma and other cultured human cancer cells. Cancer Res. 49, 6258-6264.
23. Van Echten G. and Sandhoff K. (1993) Ganglioside metabolism. Enzymology, topology, and regulation. J. Biol. Chem. 268, 5341-5344.
24. Wu G., Lu Z.-H., and Ledeen R. W. (1991) Correlation of gangliotetraose gangliosides with neunte forming potential of neuroblastoma cells. Dev. Brain Res. 61, 217-228.
25. M2 in certain cells. J. Biol. Chem. 270, 6149-6155.
26. Yamashiro S., Okada M., Haraguchi M., Furukawa K., Lloyd K. O., Shiku H., and Furukawa K. (1995b) Expression of α2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconj. J. 12, 894-900.